fda warning letter bpc-157 peptide not approved drug Therapy in Austin, TX FDA Moves to Reevaluate Several
Description
It promotes angiogenesis at the injury site, activates fibroblasts, enhances growth hormone receptor expression in tendon cells, and modulates inflammation
Individuals with pernicious anemia, characterized by a lack of intrinsic factor, are also particularly susceptible
BPC-157 is a peptide consisting of 15 amino acids
Long-term use may actually slow tendon healing at the cellular level
Available at: Accessed August 20, 2021
However, the absence of human clinical trials means the safety profile in humans is entirely unknown
